A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)
A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)
Active, not recruiting · NCT05809752 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, central nervous system cancer, neoplasm, nervous system disorder, skin disorder, triple-negative breast carcinoma, tumor of meninges | Active, not recruiting | Phase 1 | 2026-09-15 | NCT05809752 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| H. Lee Moffitt Cancer Center and Research Institute | 162 |
| United States Department of Defense | 319 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Moffitt Cancer Center | Tampa | United States | 523 |